Given the pivotal role of PI3K signalling in controlling cell growth, survival and proliferation, key components of this pathway, PI3K, mTOR (mammalian target of rapamycin) and Akt, have emerged as promising targets for cancer drug discovery [2,3]. The gene discussed is AKT1; the disease is cancer.